We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Case Study: A 62-Year-Old Male With CTEPH
George Hanna, MD
HFpEF – Diagnostic Approach Through Case Review
Yasmin Raza, MD
Panel Discussion: Real-World Issues in CTD-PAH Screening, Diagnosis, and Management
Michael J. Cuttica, MD, MS
Victor Moles, MD
Vallerie V. McLaughlin, MD
Ruben Mylvaganam, MD
Epidemiology and Management of Left Heart Disease Associated PH
Thomas Cascino, MD
Screening, Diagnosis, and Treatment of PH-ILD
CTEPH & CTED -Current Epidemiology and Trends
Midwest Regional PH Summit – Management of Pulmonary Hypertension with Comorbidities
Daniel Schimmel, MD
Jonathan Haft, MD
Sydney Schacht, DO
Ravi B. Patel, MD, MSc
While the DOAC Revolution Has Occurred, 40-50% of Patients Remain Untreated... Why?
Elaine Hylek, MD, MPH
US Perspective on ESC/ERS Guidelines
Panel: Issues Dealing with Left Heart Disease in PH
New Frontiers in Anticoagulation: Factor XI/XIa Inhibitors
Christopher B. Granger, MD
Manesh R. Patel, MD
M. Cecilia Bahit, MD
While DOACs are Good for Some Things, They Are Not for Everyone
Balloon Pulmonary Angioplasty: Issues and Perspectives
Questions & Answers from the AHA 2023 Symposium
Clinical Trials in HFpEF: What Have They Taught Us?
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education